Chinese Medical E-ournals Database

Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition) ›› 2021, Vol. 17 ›› Issue (04): 446 -452. doi: 10.3877/cma.j.issn.1673-5250.2021.04.011

Original Article

Twin pregnancy combined with hypertrophic cardiomyopathy: a case report and literature review

Jiaxin Gu, Hua Liao, Haiyan Yu()   

  • Received:2021-01-05 Revised:2021-04-19 Published:2021-08-01
  • Corresponding author: Haiyan Yu
  • Supported by:
    Key Research and Development Project of Sichuan Science and Technology Department(2018FZ0041); Academic and Technical Leader Training Project of Sichuan Province([2017]919-25)
Objective

To investigate clinical characteristics of twin pregnancy combined with hypertrophic cardiomyopathy (HCM) and review related literature.

Methods

A pregnant woman with a gestational age of 33+ 5 gestational weeks who admitted to the Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University with twin pregnancy combined with HCM on October 12, 2017 was included into this study. The clinical data, characteristics and treatment process were retrospectively analyzed, and related literature were reviewed. In this study, the literature review of HCM in twin pregnancy was conducted with the following keywords " hypertrophic cardiomyopathy" " twin pregnancy" " cardiomyopathy" " twin pregnancy" " hypertrophic cardiomyopathy" and " cardiomyopathy" . The search period was set from database inception to January 1, 2020, and the clinical characteristics and treatment protocols of the disease were summarized. This study met the requirements of World Medical Association Declaration of Helsinki revised in 2013.

Results

The clinical data and consultation process of this patient were collected as follows. ①This patient was 30 years old, post-in vitro fertilization-embryo transfer (IVF-ET) (two frozen embryos were transferred), with a history of HCM for 4+ years. The patient was repeatedly informed of the risks and after full assessment by the multiple disciplinary team (MDT), the patient underwent regular prenatal check up under the supervision of the Department of Obstetrics and Cardiology. Due to premature rupture of membranes (PROM), the patient underwent an emergency cesarean section at 34+ 1 weeks′ gestation under general anesthesia after assessment by the MDT, and the operation was successful. Immediately after surgery, she was transferred to the intensive care unit (ICU) for monitoring. Postoperatively, the patient developed acute heart failure, which stabilized after treatment with respiratory support, sedation, anti-infection, reduction of volume load and improvement of cardiac function, etc.. The patient was evaluated by a cardiovascular specialist and given beta-lactone to control the ventricular rate and reduce myocardial oxygen consumption. Two days after surgery, the condition was improved and this patient was transferred back to the obstetrics ward. She is still being followed up and both mother and baby are in good condition. ②Results of literature review were as follow. According to the literature search strategy of this study, no relevant reports of twin pregnancy combined with HCM were retrieved, so the search was expanded by changing keywords from " twin" to " pregnancy" , and a total of 12 articles were retrieved. Among these 12 articles, a total of 260 cases of pregnancy with HCM were retrieved, involving a total of 284 pregnancies, all of which were singleton pregnancy. Among these 284 pregnancies, 28 cases of heart failure occurred; 2 patients died, and the remaining patients with heart failure were treated effectively and their condition improved. Except for 52 pregnancies in which the neonatal outcome was unknown, there were 46 cases of preterm fetal delivery and 5 cases of intrauterine fetal death in the remaining 232 pregnancies.

Conclusions

Most patients with asymptomatic or mild HCM can tolerate pregnancy and have good maternal and infant outcomes. However, in patients with HCM in multiple pregnancies, even if no maternal adverse cardiovascular events occurred during pregnancy, the rapid change in blood volume after delivery will be a great challenge for patients with cardiomyopathy.

[1]
陈鹏正,李磊,王谢桐. 妊娠合并先天性心脏病的综合管理[J]. 中国实用妇科与产科杂志201935(11):1205-1210. DOI: 10.19538/j.fk2019110106.
[2]
谢幸,孔北华,段涛. 妇产科学[M]. 9版.北京:人民卫生出版社,2018.
[3]
Deng C, Dai L, Yi L, et al. Temporal trends in the birth rates and perinatal mortality of twins: a population-based study in China[J]. PLoS One, 2019, 14(1): e0209962. DOI: 10.1371/journal.pone.0209962.
[4]
Lavie A, Ram M, Lev S, et al. Maternal hemodynamics in late gestation and immediate postpartum in singletons vs. twin pregnancies[J]. Arch Gynecol Obstet, 2018, 297(2): 353-363. DOI: 10.1007/s00404-017-4601-8.
[5]
Ommen SR, Mital S, Burke MA, et al. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines[J]. J Am Coll Cardiol, 2020, 76(25): 3022-3055. DOI: 10.1016/j.jacc.2020.08.044.
[6]
Lima FV, Parikh PB, Zhu J, et al. Association of cardiomyopathy with adverse cardiac events in pregnant women at the time of delivery[J]. JACC Heart Fail, 2015, 3(3): 257-266. DOI: 10.1016/j.jchf.2014.10.008. PMID: 25742764.
[7]
中华医学会心血管病学分会,中国成人肥厚型心肌病诊断与治疗指南编写组,中华心血管病杂志编辑委员会. 中国成人肥厚型心肌病诊断与治疗指南[J]. 中华心血管病杂志201745 (12): 1015-1032. DOI: 10.3760/cma.j.issn.0253-3758.2017.12.005
[8]
熊峰. 梗阻性肥厚型心肌病治疗方法的现状与进展[J]. 心血管病学进展2019, 40(6): 889-893. DOI: 10.16806/j.cnki.issn.1004-3934.2019.06.013.
[9]
Geske JB, Ommen SR, Gersh BJ. Hypertrophic cardiomyopathy: clinical update[J]. JACC Heart Fail, 2018, 6(5): 364-375. DOI: 10.1016/j.jchf.2018.02.010.
[10]
张军.妊娠合并心脏病的多学科(分层)管理[J]. 中国全科医学2019, 22(3):10-15.DOI:10.12114/j.issn.1007-9572.2018.00.381.
[11]
Marian AJ, Braunwald E. Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy[J]. Circ Res, 2017, 121(7): 749-770. DOI: 10.1161/CIRCRESAHA.117.311059.
[12]
Makavos G, Κairis C, Tselegkidi ME, et al. Hypertrophic cardiomyopathy: an updated review on diagnosis, prognosis, and treatment[J]. Heart Fail Rev, 2019, 24(4): 439-459. DOI: 10.1007/s10741-019-09775-4.
[13]
Roos-Hesselink JW, Ruys TP, Stein JI, et al. Outcome of pregnancy in patients with structural or ischaemic heart disease: results of a registry of the European Society of Cardiology[J]. Eur Heart J, 2013, 34(9): 657-665. DOI: 10.1093/eurheartj/ehs270.
[14]
Eghbali M, Wang Y, Toro L, et al. Heart hypertrophy during pregnancy: a better functioning heart?[J]. Trends Cardiovasc Med, 2006, 16(8): 285-291. DOI: 10.1016/j.tcm.2006.07.001.
[15]
Iacobaeus C, Andolf E, Thorsell M, et al. Cardiac function, myocardial mechano-energetic efficiency, and ventricular-arterial coupling in normal pregnancy[J]. J Hypertens, 2018, 36(4): 857-866. DOI: 10.1097/HJH.0000000000001612.
[16]
Billebeau G, Etienne M, Cheikh-Khelifa R, et al. Pregnancy in women with a cardiomyopathy: outcomes and predictors from a retrospective cohort[J]. Arch Cardiovasc Dis, 2018, 111(3): 199-209. DOI: 10.1016/j.acvd.2017.05.010.
[17]
Goland S, van Hagen IM, Elbaz-Greener G, et al. Pregnancy in women with hypertrophic cardiomyopathy: data from the European Society of Cardiology initiated Registry of Pregnancy and Cardiac disease (ROPAC)[J]. Eur Heart J, 2017, 38(35): 2683-2690. DOI: 10.1093/eurheartj/ehx189.
[18]
Schaufelberger M. Cardiomyopathy and pregnancy[J]. Heart, 2019, 105(20): 1543-1551. DOI: 10.1136/heartjnl-2018-313476.
[19]
中华医学会妇产科学分会产科学组. 妊娠合并心脏病的诊治专家共识(2016)[J]. 中华妇产科杂志2016, 51(6):401-409. DOI: 10.3760/cma.j.issn.0529-567x.2016.06.001.
[20]
Schinkel AF. Pregnancy in women with hypertrophic cardiomyopathy[J]. Cardiol Rev, 2014, 22(5): 217-222. DOI: 10.1097/CRD.0000000000000010.
[21]
Thaman R, Varnava A, Hamid MS, et al. Pregnancy related complications in women with hypertrophic cardiomyopathy[J]. Heart, 2003, 89(7): 752-756. DOI: 10.1136/heart.89.7.752.
[22]
Elliott PM, Anastasakis A, Borger MA, et al. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)[J]. Eur Heart J, 2014, 35(39): 2733-2779. DOI: 10.1093/eurheartj/ehu284.
[23]
Tanaka H, Kamiya C, Katsuragi S, et al. Cardiovascular events in pregnancy with hypertrophic cardiomyopathy[J]. Circ J, 2014, 78(10): 2501-2506. DOI: 10.1253/circj.cj-14-0541.
[24]
Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy[J]. Eur Heart J, 2018, 39(34): 3165-3241. DOI: 10.1093/eurheartj/ehy340.
[25]
Kametas NA, McAuliffe F, Krampl E, et al. Maternal cardiac function in twin pregnancy[J]. Obstet Gynecol, 2003, 102(4): 806-815. DOI: 10.1016/s0029-7844(03)00807-x.
[26]
Lewey J, Haythe J. Cardiomyopathy in pregnancy[J]. Semin Perinatol, 2014, 38(5): 309-317. DOI: 10.1053/j.semperi.2014.04.021.
[27]
Orabona R, Prefumo F, Zanardini C, et al. Maternal functional hemodynamics in uncomplicated twin pregnancies: a longitudinal study using impedance cardiography[J]. Acta Obstet Gynecol Scand, 2019, 98(2): 188-195. DOI: 10.1111/aogs.13479.
[28]
苏晞,鄢华. 2018年欧洲心脏病学会妊娠期心血管疾病管理指南解读[J]. 中国介入心脏病学杂志2018, 26(9): 481-487. DOI: 10.3969/j.issn.1004-8812.2018.09.001.
[29]
钱芳,张欣,刘亚静,等. 妊娠合并肥厚型心肌病1例[J]. 中国实用妇科与产科杂志2011, 27(3): 233.
[1] Yigang Wu, Yumin Pan, Shanshan Wu, Mengjuan Hu, Yiwei Wang, Jinsong Zhang, Li Qiao. Efficacy of levosimendan in the treatment of pulmonary hypertension combined with right heart failure: a meta-analysis[J]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2024, 17(05): 385-391.
[2] Jingyu Qian, Mingming Zheng. Interpretation of the Italian guidelines on non-invasive and invasive prenatal diagnosis:executive summary of recommendations for practice the Italian Society for Obstetrics and Gynecology(SIGO)[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 486-492.
[3] Xialin Li, Fang He. Risk assessment and early warning system for postpartum hemorrhage[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 498-503.
[4] Yiming Fei, Zhuo Liu, Lijuan Zhang. Current research status of omics analysis in the molecular mechanism of preterm birth[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 504-510.
[5] Ziyang Liu, Jianjian Cui, Yin Zhao. Current research status on obstetric disseminated intravascular coagulation and its scoring system[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 511-518.
[6] Fanying Zeng, Jie Ruan, Xinghui Liu, Guolin He. Current status of perinatal medicine advances under the new reproductive situation and coping strategies in prenatal care[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 519-524.
[7] Xiaofei Li, Hongli Liu, Qiuling Shi, Jing Tian, Li Li, Hongbo Qi, Xin Luo. A prospective randomized controlled study of low intensity focused ultrasound uterine involution treatment for prevention and treatment of postpartum hemorrhage in natural childbirth women[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 534-539.
[8] Rong Huang, Ziyu Liang, Wenjin Qi. Expression and significance of NLRP3 inflammasome in serum of pregnant women with premature rupture of membranes[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 540-548.
[9] Xia He, Rong Huang, Wenjin Qi. High-throughput sequencing study on the abundance of placenta and fetal membrane flora in pregnant women with premature rupture of membranes[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 549-555.
[10] Jiangyan Xie, Yafei Wang, Fang He. Pregnancy complicated with thrombotic thrombocytopenic purpura:two cases report and literature review[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 556-563.
[11] Xiaoyan Han, Hua Yang. Relationship between low level of serum placental growth factor in the second trimester pregnancy women and adverse fetal prognosis[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(04): 398-402.
[12] Jiali Du, Rui Bao, Chunhong Qiao, Wei Han. Construction of a prediction model for adverse pregnancy outcomes after emergency cervical cerclage in pregnant women with cervical incompetence during the second trimester[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(04): 403-409.
[13] Tingting Xu, Yongchi Zhan, Xiaodong Wang, Xiaodong Wang. Perinatal outcomes of fetomaternal hemorrhage syndrome pregnant women with sinusoidal fetal heart tracing[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(04): 382-389.
[14] Huihui Yu, Zongzhi Yin. Gastric perforation during pregnancy[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2024, 13(04): 209-213.
[15] Shan Lu, Yunshan Yao, Seni Liao, Zien Chen, Yijian Zhang, Jianhao Lan, Wei Wei, Yanyang Liu, Yanhong Chen, Duijin Chen. Clinical study of 100 cases of suspected pregnancy complicated with acute appendicitis[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2024, 13(04): 214-219.
Viewed
Full text


Abstract